Home
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- Modern Science Confirms Ancient Wisdom!
- Modern Science Confirms Ancient Wisdom!
- "Natural" or "Plant-Derived" Labeling Can Mislead
- CDN: Natural Health Products Report - Update
- NPI Editorial: Are we using Best Practices?
- AHPA Update: Kava Information from the AHPA Executive Committee
- European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing
- Statement on Kava in New Zealand
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- Kerry Announces Further Expansion of its North American Sweet Ingredients Business
Company announces acquisition of Custom Industries and Nuvex Ingredients for total consideration of US$83m.
- Kerry Announces Further Expansion of its North American Sweet Ingredients Business
Company announces acquisition of Custom Industries and Nuvex Ingredients for total consideration of US$83m.
- Kerry Announces Further Expansion of its North American Sweet Ingredients Business
Company announces acquisition of Custom Industries and Nuvex Ingredients for total consideration of US$83m.
- USANA Reports Record First Quarter Net Sales
Company reports Q1 net sales of $89.7 million, compared with $76.6 million in the first quarter of the prior year, with net earnings of $9.6 million compared with net earnings of $8.9 million in the first quarter of the prior year.
- USANA Reports Record First Quarter Net Sales
Company reports Q1 net sales of $89.7 million, compared with $76.6 million in the first quarter of the prior year, with net earnings of $9.6 million compared with net earnings of $8.9 million in the first quarter of the prior year.
- NeoCell Corporation Files for Patent Protection on Canine and Equine Collagen Joint Health Supplement
Company announces the filing of patent protection on ArthroPet(TM), made with kolla2®.
- NeoCell Corporation Files for Patent Protection on Canine and Equine Collagen Joint Health Supplement
Company announces the filing of patent protection on ArthroPet(TM), made with kolla2®.
- NeoCell Corporation Files for Patent Protection on Canine and Equine Collagen Joint Health Supplement
Company announces the filing of patent protection on ArthroPet(TM), made with kolla2®.
- NeoCell Corporation Files for Patent Protection on Canine and Equine Collagen Joint Health Supplement
Company announces the filing of patent protection on ArthroPet(TM), made with kolla2®.
- Nutri Pharmaceuticals Research Inc. Reports First Quarter Earnings
Company reports sales of $421,000 as compared to $290,000 in first quarter of the prior year, with profit approximated at$339,000, compared to $207,000 in same period of the prior year.
- Nutri Pharmaceuticals Research Inc. Reports First Quarter Earnings
Company reports sales of $421,000 as compared to $290,000 in first quarter of the prior year, with profit approximated at$339,000, compared to $207,000 in same period of the prior year.
- Neptune Technologies & Bioressources Inc. Appoints V.P. Sales & Marketing
Mr. Donald Allard has joined Neptune as the Vice President, Sales and Marketing, to be involved in all aspects of the sales process and marketing, including business development, branding, customer relations, and promotion.
- Neptune Technologies & Bioressources Inc. Appoints V.P. Sales & Marketing
Mr. Donald Allard has joined Neptune as the Vice President, Sales and Marketing, to be involved in all aspects of the sales process and marketing, including business development, branding, customer relations, and promotion.
- Neptune Technologies & Bioressources Inc. Appoints V.P. Sales & Marketing
Mr. Donald Allard has joined Neptune as the Vice President, Sales and Marketing, to be involved in all aspects of the sales process and marketing, including business development, branding, customer relations, and promotion.
- Neptune Technologies & Bioressources Inc. Appoints V.P. Sales & Marketing
Mr. Donald Allard has joined Neptune as the Vice President, Sales and Marketing, to be involved in all aspects of the sales process and marketing, including business development, branding, customer relations, and promotion.
- DENOMEGA NUTRITIONAL OILS; New name for Denofa Nutritional Oils
Denofa Nutritional Oils, a former division of Denofa, is changing its name to Denomega Nutritional Oils.
- DENOMEGA NUTRITIONAL OILS; New name for Denofa Nutritional Oils
Denofa Nutritional Oils, a former division of Denofa, is changing its name to Denomega Nutritional Oils.
- DENOMEGA NUTRITIONAL OILS; New name for Denofa Nutritional Oils
Denofa Nutritional Oils, a former division of Denofa, is changing its name to Denomega Nutritional Oils.
- DENOMEGA NUTRITIONAL OILS; New name for Denofa Nutritional Oils
Denofa Nutritional Oils, a former division of Denofa, is changing its name to Denomega Nutritional Oils.
- DENOMEGA NUTRITIONAL OILS; New name for Denofa Nutritional Oils
Denofa Nutritional Oils, a former division of Denofa, is changing its name to Denomega Nutritional Oils.
- DENOMEGA NUTRITIONAL OILS; New name for Denofa Nutritional Oils
Denofa Nutritional Oils, a former division of Denofa, is changing its name to Denomega Nutritional Oils.
- KGK Synergize Inc., Seeks Private Placement for Growth; JANUS CORPORATE FINANCE Retained as Principal Advisor
Company has retained Janus Corporate Finance to act as principal financial advisor in arranging additional growth capital for its emerging nutraceutical product technologies.
- KGK Synergize Inc., Seeks Private Placement for Growth; JANUS CORPORATE FINANCE Retained as Principal Advisor
Company has retained Janus Corporate Finance to act as principal financial advisor in arranging additional growth capital for its emerging nutraceutical product technologies.
- Paul Intlekofer Elected CEO of Nutrition 21
Company's Board of Directors has elected Paul Intlekofer as president and chief executive officer.
- Paul Intlekofer Elected CEO of Nutrition 21
Company's Board of Directors has elected Paul Intlekofer as president and chief executive officer.
- Paul Intlekofer Elected CEO of Nutrition 21
Company's Board of Directors has elected Paul Intlekofer as president and chief executive officer.
- Paul Intlekofer Elected CEO of Nutrition 21
Company's Board of Directors has elected Paul Intlekofer as president and chief executive officer.
- Neptune Technologies & Bioressources Inc. Reports Third Quarter Results
Company reports revenues of $1,822,000 compared to $1,292,000 for the prior year, with a net profit of $1,038,000 or $0.032 per share for the quarter.
- Neptune Technologies & Bioressources Inc. Reports Third Quarter Results
Company reports revenues of $1,822,000 compared to $1,292,000 for the prior year, with a net profit of $1,038,000 or $0.032 per share for the quarter.
- EuroPharma Now Offering Products Utilizing New Patented Coating Technology For Specific Uses
Company is partnering with a European company to bring a new proprietary and patented enteric coating technology, which preserves active ingredients, to US companies for tablet applications.
- EuroPharma Now Offering Products Utilizing New Patented Coating Technology For Specific Uses
Company is partnering with a European company to bring a new proprietary and patented enteric coating technology, which preserves active ingredients, to US companies for tablet applications.
- EuroPharma Now Offering Products Utilizing New Patented Coating Technology For Specific Uses
Company is partnering with a European company to bring a new proprietary and patented enteric coating technology, which preserves active ingredients, to US companies for tablet applications.
- EuroPharma Now Offering Products Utilizing New Patented Coating Technology For Specific Uses
Company is partnering with a European company to bring a new proprietary and patented enteric coating technology, which preserves active ingredients, to US companies for tablet applications.
- EuroPharma Now Offering Products Utilizing New Patented Coating Technology For Specific Uses
Company is partnering with a European company to bring a new proprietary and patented enteric coating technology, which preserves active ingredients, to US companies for tablet applications.
- EuroPharma Now Offering Products Utilizing New Patented Coating Technology For Specific Uses
Company is partnering with a European company to bring a new proprietary and patented enteric coating technology, which preserves active ingredients, to US companies for tablet applications.
- Nutraceutical Reports Sales and Income
Company reports net sales for the fiscal 2006 second quarter were $41.0 million compared to $38.8 million prior year, with net income of $5.0 million, or $0.43 diluted earnings per share, compared to $3.5 million, or $0.29 diluted earnings per share, for the same quarter of fiscal 2005.
- Nutraceutical Reports Sales and Income
Company reports net sales for the fiscal 2006 second quarter were $41.0 million compared to $38.8 million prior year, with net income of $5.0 million, or $0.43 diluted earnings per share, compared to $3.5 million, or $0.29 diluted earnings per share, for the same quarter of fiscal 2005.
- Advitech Inc Announces Agreement with Enbio-Life for Dermylex in Taiwan
Company has announced that it has reached an agreement in principle regarding a marketing and distribution agreement for its Dermylex(TM) product with Taiwan-based Enbio-Life Biotechnology & Medical Company Ltd, ("Enbio-Life"), a subsidiary of Yusheng Pharma.
- Advitech Inc Announces Agreement with Enbio-Life for Dermylex in Taiwan
Company has announced that it has reached an agreement in principle regarding a marketing and distribution agreement for its Dermylex(TM) product with Taiwan-based Enbio-Life Biotechnology & Medical Company Ltd, ("Enbio-Life"), a subsidiary of Yusheng Pharma.
- NBTY Reports Second Quarter Results
Company reports net sales of $482 million compared to net sales of $443 million prior year, with $39 million increase including $32 million in net sales from NBTY's recent acquisitions: $26 million from Solgar, $3 million from LeNaturiste and $3 million from SISU. Net income was $21 million, or $0.31 per diluted share, compared to $21 million, or $0.30 per diluted share, for the fiscal second quarter ended March 31, 2005.
- NBTY Reports Second Quarter Results
Company reports net sales of $482 million compared to net sales of $443 million prior year, with $39 million increase including $32 million in net sales from NBTY's recent acquisitions: $26 million from Solgar, $3 million from LeNaturiste and $3 million from SISU. Net income was $21 million, or $0.31 per diluted share, compared to $21 million, or $0.30 per diluted share, for the fiscal second quarter ended March 31, 2005.
- Phosphagenics & Nestle Nutrition Sign Agreement for Development of Phospha E(R) for Foods and Beverages
Phosphagenics Limited and Nestle Nutrition, a unit of Nestle S.A. have entered into a research agreement to develop Phosphagenics' Phospha E(R) for use in Nestle Nutrition's products.
- Phosphagenics & Nestle Nutrition Sign Agreement for Development of Phospha E(R) for Foods and Beverages
Phosphagenics Limited and Nestle Nutrition, a unit of Nestle S.A. have entered into a research agreement to develop Phosphagenics' Phospha E(R) for use in Nestle Nutrition's products.
- Phosphagenics & Nestle Nutrition Sign Agreement for Development of Phospha E(R) for Foods and Beverages
Phosphagenics Limited and Nestle Nutrition, a unit of Nestle S.A. have entered into a research agreement to develop Phosphagenics' Phospha E(R) for use in Nestle Nutrition's products.
- Natural Alternatives International, Inc. Announces Third Quarter Results
Company reports net income of $621,000 or $0.09 per diluted share compared to $277,000 or $0.04 per diluted share for the comparable quarter prior year, as net saloes increase from $22.5 million to $23.3 million, including net sales from recent acquisition Real Health Laboratories of $2.7 million for the quarter.
- Natural Alternatives International, Inc. Announces Third Quarter Results
Company reports net income of $621,000 or $0.09 per diluted share compared to $277,000 or $0.04 per diluted share for the comparable quarter prior year, as net saloes increase from $22.5 million to $23.3 million, including net sales from recent acquisition Real Health Laboratories of $2.7 million for the quarter.
- Indena Signs Long-Term Agreement With Alliance Principle Ingredients As Its Canadian Distributor
Indena has named Alliance Principle Ingredients as its Canadian distributor for its line of herbal & plant extracts for use in dietary supplements and food products.
- Indena Signs Long-Term Agreement With Alliance Principle Ingredients As Its Canadian Distributor
Indena has named Alliance Principle Ingredients as its Canadian distributor for its line of herbal & plant extracts for use in dietary supplements and food products.
- Indena Signs Long-Term Agreement With Alliance Principle Ingredients As Its Canadian Distributor
Indena has named Alliance Principle Ingredients as its Canadian distributor for its line of herbal & plant extracts for use in dietary supplements and food products.
- Indena Signs Long-Term Agreement With Alliance Principle Ingredients As Its Canadian Distributor
Indena has named Alliance Principle Ingredients as its Canadian distributor for its line of herbal & plant extracts for use in dietary supplements and food products.
- Nu Skin Enterprises Reports First-Quarter 2006 Results
Company reports revenue of $265.8 million and a loss per share of $0.18 with net loss of $12.8 million and $0.18, compared to net income of $17.7 million and earnings per share of $0.25 during the first quarter of 2005.
- Nu Skin Enterprises Reports First-Quarter 2006 Results
Company reports revenue of $265.8 million and a loss per share of $0.18 with net loss of $12.8 million and $0.18, compared to net income of $17.7 million and earnings per share of $0.25 during the first quarter of 2005.
- Nu Skin Enterprises Announces New Corporate Organization and Appoints Executives to Key Positions
Dan Chard, former head of the company's European operations, has been appointed to the position of executive vice president, distributor success, Dr. Joe Chang, former president of the Pharmanex division, has been appointed to serve as the company's chief scientific officer and executive vice president, product development, Lori Bush, former president of the company's Nu Skin division, will be engaged as a consultant and has been appointed to serve as chairwoman of the Nu Skin Scientific Advisory Board.
- Nu Skin Enterprises Announces New Corporate Organization and Appoints Executives to Key Positions
Dan Chard, former head of the company's European operations, has been appointed to the position of executive vice president, distributor success, Dr. Joe Chang, former president of the Pharmanex division, has been appointed to serve as the company's chief scientific officer and executive vice president, product development, Lori Bush, former president of the company's Nu Skin division, will be engaged as a consultant and has been appointed to serve as chairwoman of the Nu Skin Scientific Advisory Board.
- Nu Skin Enterprises Announces New Corporate Organization and Appoints Executives to Key Positions
Dan Chard, former head of the company's European operations, has been appointed to the position of executive vice president, distributor success, Dr. Joe Chang, former president of the Pharmanex division, has been appointed to serve as the company's chief scientific officer and executive vice president, product development, Lori Bush, former president of the company's Nu Skin division, will be engaged as a consultant and has been appointed to serve as chairwoman of the Nu Skin Scientific Advisory Board.
- Nu Skin Enterprises Announces New Corporate Organization and Appoints Executives to Key Positions
Dan Chard, former head of the company's European operations, has been appointed to the position of executive vice president, distributor success, Dr. Joe Chang, former president of the Pharmanex division, has been appointed to serve as the company's chief scientific officer and executive vice president, product development, Lori Bush, former president of the company's Nu Skin division, will be engaged as a consultant and has been appointed to serve as chairwoman of the Nu Skin Scientific Advisory Board.
- The Hain Celestial Group Announces Third Quarter Sales and Earnings
Company reports sales of $196.4 million in its third quarter, compared to prior year's $161.3 million, with net income of $9.7 million, versus the prior year's $7.7 million.
- The Hain Celestial Group Announces Third Quarter Sales and Earnings
Company reports sales of $196.4 million in its third quarter, compared to prior year's $161.3 million, with net income of $9.7 million, versus the prior year's $7.7 million.
- SunOpta Announces First Quarter Results
Company reports revenues of $133,312,000 as compared to $86,223,000 in the first quarter of the prior year, led by a 52.5% increase in revenues within the Company's vertically integrated natural and organic food operations, with net income of $3,012,000 or $0.053 per diluted common share as compared to $6,605,000 or $0.116 per diluted common share in the prior year.
- SunOpta Announces First Quarter Results
Company reports revenues of $133,312,000 as compared to $86,223,000 in the first quarter of the prior year, led by a 52.5% increase in revenues within the Company's vertically integrated natural and organic food operations, with net income of $3,012,000 or $0.053 per diluted common share as compared to $6,605,000 or $0.116 per diluted common share in the prior year.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Sunwin International Neutraceuticals Forms a Canadian Subsidiary to Distribute Chinese Herb-Based Medicines
Company has formed a wholly owned subsidiary in Canada, Sunwin (Canada) Pharmaceuticals, Limited, in order to market its Chinese herb-based medicines, including Hypericin, Honeysuckle, Angelica, Chrysanthemum, Epimedium, and Dandelion, throughout Canada
- Sunwin International Neutraceuticals Forms a Canadian Subsidiary to Distribute Chinese Herb-Based Medicines
Company has formed a wholly owned subsidiary in Canada, Sunwin (Canada) Pharmaceuticals, Limited, in order to market its Chinese herb-based medicines, including Hypericin, Honeysuckle, Angelica, Chrysanthemum, Epimedium, and Dandelion, throughout Canada
- Herbalife Ltd. Announces First-Quarter Results
Company reports net sales of $455.8 million with net income of $38.7 million, or $0.53 per diluted share, compared to $13.3 million, or $0.19 per diluted share in 2005.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- NPI Daily - Top of The News for January 8, 2009 - HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America
Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension; BBB Warns Consumers of Two Companies That Use Oprah, Other Celebrity Names, to Sell Supplements; HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America; dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD; Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink; Health Canada Releases January 2009 Issue of CARN; What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009
- NPI Daily - Top of The News for January 8, 2009 - HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America
Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension; BBB Warns Consumers of Two Companies That Use Oprah, Other Celebrity Names, to Sell Supplements; HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America; dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD; Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink; Health Canada Releases January 2009 Issue of CARN; What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
|
Santa Rosa, CA – April 26, 2006 – EcoNugenics®, a leading dietary supplement company, announced today that the United States Patent and Trademark Office (USPTO) has issued the company US Patent No. 7,026,302. This important new patent protects the use of modified alginates and modified pectins in providing support to those suffering from a wide range of diseases that may be caused or aggravated by heavy metals, environmental toxins or cholesterol.
EcoNugenics® currently markets two products that are protected by this patent and earlier patents # 6,274,566 and #6,462,029: PectaSol® Modified Citrus Pectin and PectaSol® Chelation Complex.
“This is excellent news! We are gratified that the US Patent Office has issued this patent, said Isaac Eliaz, MD, L.Ac., President and Founder of EcoNugenics®. “This issuance provides further validation of our strategy and gives us confidence to continue our research and development work on creating a product to address the rising prevalence of diabetes.”
EcoNugenics® was founded in 1995 with a commitment to offering premium dietary supplements based on the best of modern science integrated with the ancient wisdom of traditional and complementary therapies. EcoNugenics® is committed to five basic principles, which include innovation in product formulation, thorough scientific research, ongoing clinical validation, customer education/empowerment and superior quality control. For more information contact Connie St. John at 415-454-2243.
# # #
|